文献速递关节外科

金属对金属混合髋关节表面置换术的十年平均随访结果

The mean ten-year results of metal-on-metal hybrid hip resurfacing arthroplasty.
PubMed 文献 · Bone Joint J · 2018-01-01

研究纳入1996年11月至2012年1月间1074例(1321髋)接受Conserve Plus髋关节表面置换系统的患者,平均随访10.5年,15年总体生存率为89.4%(95%CI 86.8至91.4),男性特发性骨关节炎患者15年生存率达94.5%,女性为82.2%(p=0.001)。作者认为金属对金属髋关节表面置换术是可行概念,在合理设计的假体与正确植入下金属对金属轴承适合该手术。

要点

  • 15年总体生存率(以任何原因翻修为终点)为89.4%(95%CI 86.8至91.4)。
  • 男性特发性骨关节炎患者15年生存率为94.5%,女性为82.2%(p=0.001)。
  • 以过度磨损翻修为终点(离子水平>7 µg/l伴症状或不良局部组织反应)的15年生存率为98.5%。

核心结论

  • 髋关节表面置换术是可行概念;当假体设计良好且植入正确时,金属对金属轴承适合该手术。
  • 男性骨关节炎患者结果最佳,但技术改进后其他基础病理和女性患者的生存率有所改善。
  • 尽管活动水平高,许多患者可能获得终生耐久性。

研究设计与样本

  • 回顾性分析1996年11月至2012年1月间1074例(1321髋)接受Conserve Plus髋关节表面置换系统行金属对金属髋关节表面置换术的患者。
  • 患者包括787名男性(73%)和287名女性(27%),平均年龄51岁(14至83岁)。
  • 基础病理为骨关节炎1003髋(75.9%)、髋关节发育不良136髋(10.3%)、股骨头缺血性坏死98髋(7.4%)及其他情况(包括炎性关节炎)84髋(6.4%)。

主要发现

  • 平均随访10.5年(1至20年)。
  • 以任何原因翻修为终点,15年总体生存率为89.4%(95%CI 86.8至91.4)。
  • 第一代与第二代手术技术之间生存率显著提高(86.6% vs 90.1%;p=0.05)。
  • 男性特发性骨关节炎患者15年生存率为94.5%,女性为82.2%(p=0.001);按假体组件尺寸和病因分层后性别不再是危险因素。
  • 以过度磨损翻修为终点(离子水平>7 µg/l伴症状或不良局部组织反应),15年生存率为98.5%。

关键数值与推荐

  • 所有失败模式翻修的危险因素包括:基础病理为髋关节发育不良、接触面至边缘(CPR)距离≤7 mm、手术年龄≤55岁、股骨组件尺寸≤46 mm。
  • 股骨组件无菌性松动的特定危险因素包括:早期手术技术、非骨水泥干骺端柄、体重指数≤24 kg/m2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study presents the long-term survivorship, risk factors for prosthesis survival, and an assessment of the long-term effects of changes in surgical technique in a large series of patients treated by metal-on-metal (MoM) hip resurfacing arthroplasty (HRA). PATIENTS AND METHODS: Between November 1996 and January 2012, 1074 patients (1321 hips) underwent HRA using the Conserve Plus Hip Resurfacing System. There were 787 men (73%) and 287 women (27%) with a mean age of 51 years (14 to 83). The underlying pathology was osteoarthritis (OA) in 1003 (75.9%), developmental dysplasia of the hip (DDH) in 136 (10.3%), avascular necrosis in 98 (7.4%), and other conditions, including inflammatory arthritis, in 84 (6.4%). RESULTS: The mean follow-up time was 10.5 years (1 to 20). Using revision for any reason as the endpoint, the overall survivorship at 15 years was 89.4% (95% confidence interval (CI) 86.8 to 91.4). There was a substantial increase between the first and second generation of surgical technique (86.6% vs 90.1%; p = 0.05). Men with idiopathic OA had a 15-year survivorship of 94.5% and women, 82.2% (p = 0.001); gender was not a risk factor after stratification by component size and aetiology. Using revision for excessive wear (ion levels > 7 µg/l associated with symptoms or adverse local tissue reactions) as the endpoint, the 15-year survivorship was 98.5%. Risk factors for revision for all modes of failure were an underlying pathology of hip dysplasia, a contact patch to rim (CPR) distance of 7 mm or less, an age at surgery of 55 years or less, and a femoral component size of 46 mm or less. Specific risk factors for aseptic failure of the femoral component were early surgical technique, a cementless metaphyseal stem, and a body mass index of 24 kg/m2 or less. CONCLUSION: HRA is a viable concept; metal-on-metal bearings are well suited for this procedure when a well-designed device is properly implanted. The best results were obtained in men with OA, but survivorship was better for other underlying pathologies and for women after changes were made to the technique of implantation. Lifetime durability is a possible outcome for many patients despite a high level of activity. Cite this article: Bone Joint J 2018;100-B:1424-33.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Amstutz HC, Le Duff MJ. The mean ten-year results of metal-on-metal hybrid hip resurfacing arthroplasty. Bone Joint J. 2018. PMID: 30418058. doi:10.1302/0301-620X.100B11.BJJ-2017-1459.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。